At Invitae, we are committed to continually refining our services with the goal of offering the most comprehensive and medically-actionable genetic tests for our patients. To that end we’re excited to announce an update to our hereditary cancer testing menu. Genes added to our primary panels are genes that have a strong association with cancer risk and are therefore increasing panel sensitivity. For genes being added to the preliminary evidence group, emerging evidence shows that these genes are associated with cancer risk. Invitae’s panels are fully customizable for your convenience and the benefit of your patients.
Our tests have been updated with the following changes:
Invitae is dedicated to making genetic testing more accessible and affordable than ever before. If you have any questions about our new updates, please contact our Client Services team.